 GERMANTOWN, Md., March 29, 2021 GLOBE NEWSWIRE -- Orgenesis Inc . NASDAQ: ORGS Orgenesis or the Company, a global biotech company working to unlock the full potential of cell and gene therapies, announces that it has entered a collaboration with the Bambino Gesù Childrens Hospital in Rome to establish a Point of Care Cell Therapy center at the Hospital. Process work will be focused on supporting clinical trials related to therapies developed by both the Hospital and Orgenesis, joint research, development of new approaches, and validation activities for advanced cell and gene therapies. 